Take a look at some important dates ahead of PFD Week 2023.
PFD Week 2023 Important Dates
The American Urogynecologic Society's PFD Week 2023 is the year’s largest venue for those in the field of urogynecology and Female Pelvic Medicine and Reconstructive Surgery to come together for education and networking.
Present your latest findings and best practices, attend inspiring presentations and interactive workshops, engage in formal and informal dialogue, and establish or reinforce the bonds that will help you achieve the most important work of your career in Portland, Oregon or virtually on October 3-7, 2023!
November 21—Call for abstract and video reviewers opens
December 30—Abstract and video reviewer submission deadline
January 10—Call for abstracts, workshops, and roundtables opens
February 23—Workshop and roundtable submissions deadline
April 13—Abstract submission deadline
May 23—Registration opens
Laparoscopic RFA linked to enhanced pregnancy outcomes in uterine fibroid patients
May 18th 2024A recent study presented at the 2024 ACOG Clinical and Scientific Meeting reveals that laparoscopic radiofrequency ablation significantly improves pregnancy outcomes for women with uterine leiomyomas.
Read More
Identifying gaps in syphilis treatment and prenatal care among pregnant individuals
May 17th 2024Preventing congenital syphilis comes down to quick diagnosis and treatment of the infection in pregnancy, and the number of missed opportunities to do so in the United States continues to grow.
Read More
Study reveals critical gaps in care for PCOS patients
May 17th 2024A new study presented at the 2024 ACOG Annual Clinical and Scientific Meeting highlighted significant gaps in polycystic ovary syndrome (PCOS) care, revealing widespread patient dissatisfaction and the urgent need for improved provider education and comprehensive treatment approaches.
Read More
OASIS-1 trial reports reduced VMS frequency and severity from elinzanetant
May 17th 2024A recent study showcased at the 2024 ACOG Annual Clinical & Scientific Meeting unveils elinzanetant's efficacy in alleviating vasomotor symptoms, sleep disturbances, and enhancing menopause-related quality of life in postmenopausal women.
Read More